Cell Analysis Blog

Decoding Cells:

A Cell Analysis Blog

Blog posts

Showing 10/40 posts

The Trouble with ELISA

September 25th, 2019

In this article, we discuss some of the current challenges of the ELISA assay, some alternatives for immunoassay (particularly flow cytometry), and some tools and technologies that can address the limitations of ELISA and other immunoassays.

View article

How Scientists are Working to Fight the Deadliest Form of Cancer with Oncolytic Viruses

September 12th, 2019

Dr. Pierre Cordelier describes how some exciting pre-clinical data suggests oncolytic viruses could tackle pancreatic cancer

View article

Antibody Screening Tools, Improving Workflows

August 14th, 2019

Helping researchers identify, characterize and investigate new antibody candidates, fuels the growing demand for therapeutic antibodies.

View article

Immune Cell Killing, Multi-Spheroids

August 6th, 2019

It is captivating to observe how Herceptin alone, or peripheral blood mononuclear cells (PBMCs) alone, have little or no effect on multi-spheroid size or viability (fluorescence intensity) of SKOV-3 multi-spheroid proliferations.

View article

Immune Cell Killing, Single Spheroid

July 16th, 2019

Watch how Herceptin alone, or peripheral blood mononuclear cells (PBMCs) alone, have no significant effect on the growth of a SKOV-3 ovarian tumor spheroid.

View article

Investigating New Cancer Therapy Candidates with Live-Cell Imaging

July 11th, 2019

Professor Lawrence Kwong gives an overview of his research into cancer and the mechanisms that he and his research team are looking to target with novel therapy candidates.

View article

Harnessing the Power of the Immune System: Optimizing T Cell Killing Cancer Immunotherapy

May 22nd, 2019

Immunotherapy has emerged as a real game-changer in cancer therapeutics. After decades of research, there is now hope of boosting an individual’s own immune system to fight cancer by tapping into T cell-based therapies. One group of patients particularly benefiting from these new approaches are those with malignancies previously considered ‘difficult to treat’. Novel immune therapies include chimeric antigen receptor T cell (CAR-T) therapy and TCR-based adoptive T cell (TCR-T) therapy.

View article

Benefits of live-cell analysis for stem cell workflows

May 1st, 2019

Censo Biotechnologies is a leader in the development of induced Pluripotent Stem Cells (iPSCs) and their differentiation into specific cell types for use in drug discovery. Censo provides a full spectrum of services to pharmaceutical companies, such as iPSC generation, genome editing, optimization of differentiation, and assay industrialization.

View article

Recent trends in immuno-oncology research and therapy

April 30th, 2019

Some of the challenges in understanding immuno-oncology (I-O) research and treating cancer using I-O therapies arise from the complex interactions between a patient’s immune system and the tumor’s biology. After all, tumors are populations of cells, and populations are subject to evolutionary forces.

View article

Applications/Reagents: IncuCyte reagents are presented as lyophilized products

February 28th, 2019

Many of our IncuCyte reagents are presented as lyophilized products. Did you know that bringing these reagents to ambient temperature before resuspending them will ensure that they are dissolved fully?

View article
1 2 3 4
No file selected
Stay up-to-date with what's happening at Essen BioScience

© 2020 Essen BioScience

Privacy Policy